CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleMarket cap is $21.23B, above the global median of $1.15B
- FinancialsHigh earnings quality
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.16%Above 5Y avg (0.90%)
Annual Rate
USD 2.52Paid quarterly
Payout Ratio
31.0%Sustainable
Paying Dividends
25 yr
Payback Period
96.7 yr
Last Ex-Dividend
Jun 8, 2026
Last Payment
Jun 26, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
21.23BUSDvs all stocks (USD)
Trailing P/E
27.47xvs Medical Devices peers
Revenue (TTM)
5.94BUSDvs all stocks (USD)
Profit Margin
13.18%vs Medical Devices peers
Beta
0.9220xvs all stocks
52-Week Change
-2.16%vs all stocks
Forward Annual Dividend Yield
1.16%vs all stocks
Market Capitalization
21.23BUSDvs all stocks (USD)
Enterprise Value
22.92BUSDvs all stocks (USD)
Trailing P/E
27.47xvs Medical Devices peers
Forward P/E
17.89xvs Medical Devices peers
PEG Ratio
0.5280xvs Medical Devices peers
Price to Sales (TTM)
3.58xvs Medical Devices peers
Price to Book (MRQ)
2.97xvs Medical Devices peers
Enterprise to Revenue
3.86xvs Medical Devices peers
Enterprise to EBITDA
14.35xvs Medical Devices peers
Gross Margin
43.89%vs Medical Devices peers
Profit Margin
13.18%vs Medical Devices peers
Operating Margin
20.04%vs Medical Devices peers
Return on Assets (TTM)
6.65%vs Medical Devices peers
Return on Equity (TTM)
11.37%vs Medical Devices peers
Revenue (TTM)
5.94BUSDvs all stocks (USD)
Revenue per Share (TTM)
60.45USDUpdated Jul 19, 2026Quarterly Revenue Growth
7.30%vs Medical Devices peers
Gross Profit (TTM)
2.63BUSDvs all stocks (USD)
EBITDA (TTM)
1.60BUSDvs all stocks (USD)
Net Income (TTM)
782.30MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
51.20%vs Medical Devices peers
Operating Cash Flow (TTM)
1.34BUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
837.29MUSDvs all stocks (USD)
Forward Annual Dividend Rate
2.52USDUpdated Jul 19, 2026Forward Annual Dividend Yield
1.16%vs all stocks
Trailing Annual Dividend Rate
2.46USDUpdated Jul 19, 2026Trailing Annual Dividend Yield
1.13%vs all stocks
5-Year Average Dividend Yield
0.90%vs all stocks
Payout Ratio
31.02%vs Medical Devices peers
Minority Interest (Equity)
13.60MUSDFY2026 · Mar 31, 2026EPS (Basic)
7.97USDFY2026 · Mar 31, 2026EPS (Diluted)
7.93USDFY2026 · Mar 31, 2026Basic Shares Outstanding
98.20MSharesFY2026 · Mar 31, 2026Diluted Shares Outstanding
98.20MSharesFY2026 · Mar 31, 2026Operating Cash Flow
1.29BUSDFY2026 · Mar 31, 2026Free Cash Flow
931.80MUSDFY2026 · Mar 31, 2026Cash & Cash Equivalents (End of Period)
439.60MUSDFY2026 · Mar 31, 2026Starting Profit (CF Statement)
785.10MUSDFY2026 · Mar 31, 2026Depreciation & Amortization
486.50MUSDFY2026 · Mar 31, 2026Deferred Taxes (CF)
-16.90MUSDFY2026 · Mar 31, 2026Stock-based Compensation
61.70MUSDFY2026 · Mar 31, 2026Other Non-cash Items
-5.40MUSDFY2026 · Mar 31, 2026Change in Accounts Receivable (CF)
-25.10MUSDFY2026 · Mar 31, 2026Change in Accounts Payable (CF)
51.10MUSDFY2026 · Mar 31, 2026Change in Other Assets/Liabilities
-46.70MUSDFY2026 · Mar 31, 2026Capital Expenditures
-358.50MUSDFY2026 · Mar 31, 2026Net Acquisitions
-20.10MUSDFY2026 · Mar 31, 2026Purchase of Investments
-134.00MUSDFY2026 · Mar 31, 2026Sale of Investments
0.00USDFY2026 · Mar 31, 2026Other Investing Activity
100.00KUSDFY2026 · Mar 31, 2026Net Investing Cash Flow
-512.50MUSDFY2026 · Mar 31, 2026Long-term Debt Issuance
3.00MUSDFY2026 · Mar 31, 2026Long-term Debt Payments
-125.00MUSDFY2026 · Mar 31, 2026Common Stock Repurchase
-235.50MUSDFY2026 · Mar 31, 2026Common Dividends Paid
-241.80MUSDFY2026 · Mar 31, 2026Other Financing Charges
-1.80MUSDFY2026 · Mar 31, 2026Net Financing Cash Flow
-601.10MUSDFY2026 · Mar 31, 2026Shares Outstanding
97.80MSharesUpdated Jul 19, 2026Float Shares
97.18MSharesUpdated Jul 19, 2026Shares Short
2.34MSharesUpdated Jul 19, 2026Short Ratio
2.64daysvs all stocks
Short % of Shares Outstanding
2.41%vs all stocks
% Held by Insiders
0.31%vs all stocks
% Held by Institutions
100.86%vs all stocks
Total Cash (MRQ)
439.60MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
4.50USDUpdated Jul 19, 2026Total Debt (MRQ)
2.09BUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.2900xvs Medical Devices peers
Current Ratio (MRQ)
2.09xvs Medical Devices peers
Book Value per Share (MRQ)
73.45USDUpdated Jul 19, 2026Total Assets
10.74BUSDvs all stocks (USD)
Total Current Assets
2.39BUSDFY2026 · Mar 31, 2026Total Liabilities
3.54BUSDFY2026 · Mar 31, 2026Total Non-current Assets
8.34BUSDFY2026 · Mar 31, 2026Total Non-current Liabilities
2.40BUSDFY2026 · Mar 31, 2026Total Current Liabilities
1.15BUSDFY2026 · Mar 31, 2026Cash & Cash Equivalents
439.60MUSDFY2026 · Mar 31, 2026Accounts Receivable
1.09BUSDFY2026 · Mar 31, 2026Inventory
631.80MUSDFY2026 · Mar 31, 2026Accounts Payable
338.80MUSDFY2026 · Mar 31, 2026Short-term Debt
154.70MUSDFY2026 · Mar 31, 2026Deferred Revenue
59.10MUSDFY2026 · Mar 31, 2026Other Current Liabilities
271.50MUSDFY2026 · Mar 31, 2026Long-term Debt
1.93BUSDFY2026 · Mar 31, 2026Other Non-current Liabilities
22.00MUSDFY2026 · Mar 31, 2026Common Stock (Book)
4.28BUSDFY2026 · Mar 31, 2026Retained Earnings
3.02BUSDFY2026 · Mar 31, 2026Total Shareholders' Equity
7.20BUSDvs all stocks (USD)
52-Week Low
195.14USDUpdated Jul 19, 202652-Week High
269.44USDUpdated Jul 19, 202652-Week Change
-2.16%vs all stocks
Beta
0.9220xvs all stocks
50-Day MA
211.56USDUpdated Jul 19, 2026200-Day MA
235.56USDUpdated Jul 19, 2026Avg 10-Day Volume
714.19KSharesUpdated Jul 19, 2026Avg 30-Day Volume
839.98KSharesUpdated Jul 19, 2026Diluted EPS (TTM)
7.93USDUpdated Jul 19, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Receivables Heavy and Growing
Money owed by customers keeps growing, and is much of its current assets.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
High earnings qualityNotable
Earnings Quality Score: 1.89
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Market cap is $21.23B, above the global median of $1.15BNotable
Market cap (USD): 21,230,181,011Global Median: 1,146,734,693.424
Revenue is $5.94B, above the global median of $520.53MNotable
Revenue (USD): 5,935,900,160Global Median: 520,528,949.311
Levered free cash flow is $837.29M, above the global median of $16.24MNotable
Levered free cash flow (USD): 837,287,488Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Viatris Inc.
Tier 1ProductionApproval-Gated PipelineRule
United Therapeutics Corporation
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Incyte Corporation
Tier 1ProductionApproval-Gated PipelineRule
Insmed Inc.
Tier 1ProductionApproval-Gated PipelineRule
Moderna, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Roivant Sciences Ltd
Tier 1ProductionApproval-Gated PipelineRuleRisk
Sonova Holding AG
Tier 1ProductionApproval-Gated PipelineRuleFlow
Zimmer Biomet Holdings, Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Sichuan Biokin Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Neurocrine Biosciences Inc.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
The Clorox Company
1 interpretationReceivables Heavy and Growing
Concentra Group Holdings Inc.
1 interpretationReceivables Heavy and Growing
Coforge Limited
1 interpretationReceivables Heavy and Growing